Literature DB >> 6334747

Familial aggregation of Reiter's syndrome and ankylosing spondylitis: a comparative study.

A Calin, A Marder, S Marks, T Burns.   

Abstract

To determine the nature and prevalence of spondyloarthropathy (SpA) among the 1st degree relatives of probands with either Reiter's syndrome (RS) or ankylosing spondylitis (AS), 599 relatives of 223 consecutive probands (110 RS and 113 AS) were blindly evaluated in a controlled study. Analysis was by questionnaire, radiographic examination without knowledge of proband or relative status and, where relevant, by chart review. No cases of RS were found among the 277 relatives of probands with AS. In contrast, 11 of 322 relatives of probands with RS did have RS which was neither temporally related in onset nor due to a common epidemic source (p less than 0.01). There were 18 cases of AS among the relatives of the probands with AS compared to only 7 cases among the relatives of the patients with RS (p less than 0.05). Two probands with AS each had 2 relatives with AS. Thus, the degree of familial aggregation in RS (11/110; 10%) approaches that seen in AS (16/113; 14%) and the 2 diseases tend to breed true within families. These data suggest that there may be different genetic backgrounds in patients with RS and AS, despite the fact that both conditions are typically associated with HLA-B27.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6334747

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  3 in total

1.  Coincident seronegative spondarthritis: a case report.

Authors:  C A Speed; I Haslock
Journal:  Clin Rheumatol       Date:  1996-05       Impact factor: 2.980

2.  HLA B27 and clinical features in Reiter's syndrome.

Authors:  T Tuncer; M I Arman; A Akyokus; B Bütün; S Unal
Journal:  Clin Rheumatol       Date:  1992-06       Impact factor: 2.980

Review 3.  What Have We Learned From Family-Based Studies About Spondyloarthritis?

Authors:  Félicie Costantino; Hendrick Mambu Mambueni; Roula Said-Nahal; Henri-Jean Garchon; Maxime Breban
Journal:  Front Genet       Date:  2021-06-03       Impact factor: 4.599

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.